Radiation Recall: Another Call With Tamoxifen
Author:
Open Access
- 1 January 1999
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 38 (7) , 955-960
Abstract
Tamoxifen, a nonsteroidal antioestrogen, has been used as an adjuvant therapy in patients with oestrogen-receptor positive breast cancer for more than 10 years. Few cutaneous adverse side-effects of the skin are found with this therapy. In this study we present 20 cases of adverse skin effects in relation to tamoxifen during 1979-1997 reported to the Swedish Adverse Drug Reaction Register and 1160 skin side-effects reported to the World Health Organisation's International Collaborative Programme on Drug Monitoring. One new case report of radiation recall in conjunction to tamoxifen, with no sign of reactivation despite 18 months treatment with the tamoxifen analogue toremifene is also discussed in detail. This case illustrates that toremifene can be used as a second-line therapy in patients who have received radiation recall, on tamoxifen.Keywords
This publication has 9 references indexed in Scilit:
- Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy.Journal of Clinical Oncology, 1998
- Paclitaxel and radiation-recall dermatitis.Journal of Clinical Oncology, 1994
- Radiation recall induced by tamoxifenThe Lancet, 1992
- Individual variation and dose dependency in the progression rate of skin telangiectasiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ringInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Sunlight‐Induced Radiation RecallInternational Journal of Dermatology, 1988
- The influence of the overall treatment time in radiotherapy on the acute reaction: Comparison of the effects of daily and twice-a-week fractionation on human skinInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Cutaneous complications of chemotherapeutic agentsJournal of the American Academy of Dermatology, 1983
- Late subcutaneous fibrosis following megavoltage radiotherapyJournal of the American Academy of Dermatology, 1980